Mark Hill
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- Immunotherapy and Immune Responses 2
- T-cell and B-cell Immunology 2
- Immune Cell Function and Interaction 1
- Immunodeficiency and Autoimmune Disorders 1
-
- Monoclonal and Polyclonal Antibodies Research 2
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- Roger E. McLendon (1 shared paper)Charles N. Pegram (1 shared paper)David K. Moscatello (1 shared paper)Peter A. Humphrey (1 shared paper)Shekar N. Kurpad (1 shared paper)Craig J. Reist (1 shared paper)Laura P. Hale (1 shared paper)Carol J. Wikstrand (1 shared paper)
- Journals
- The Journal of Immunology (1 paper)European Journal of Immunology (1 paper)The Journal of Experimental Medicine (1 paper)PubMed (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Mark Hill
4 papers receiving 557 citations
Peers
Comparison fields: 5 of 54
- Immunology 230
- Oncology 231
- Genetics 74
- Radiology, Nuclear Medicine and Imaging 157
- Immunology and Allergy 16
Countries citing papers authored by Mark Hill
This map shows the geographic impact of Mark Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hill more than expected).
Fields of papers citing papers by Mark Hill
This network shows the impact of papers produced by Mark Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hill. The network helps show where Mark Hill may publish in the future.
Co-authors
The 22 scholars most cited alongside Mark Hill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. | 1995 | 401 |
| 2 | 1992 | 126 | |
| 3 | 1999 | 32 | |
| 4 | 1989 | 14 |
About Mark Hill
Mark Hill is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Oncology, Epidemiology and Genetics, having authored 4 papers that have together received 573 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), T-cell and B-cell Immunology (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Influenza Virus Research Studies (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Immune Cell Function and Interaction (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Immunology (230 citations), Oncology (231 citations), Genetics (74 citations), Radiology, Nuclear Medicine and Imaging (157 citations) and Immunology and Allergy (16 citations). Mark Hill has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Roger E. McLendon, Charles N. Pegram, David K. Moscatello, Peter A. Humphrey, Shekar N. Kurpad, Craig J. Reist, Laura P. Hale, Carol J. Wikstrand, Surinder K. Batra and Jonathan R. Lamb. Their work appears in journals such as The Journal of Immunology, European Journal of Immunology, The Journal of Experimental Medicine and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.